
April 16 (Reuters) - M42
M42 ANNOUNCES STRATEGIC INVESTMENT AND PARTNERSHIP WITH JUVENESCENCE
M42 AND JUVENESCENCE WILL COLLABORATE IN DRUG DISCOVERY TO DEVELOP A PIPELINE OF INNOVATIVE MEDICINES to ADVANCE THE PREVENTION AND TREATMENT OF DISEASES OF HIGH UNMET NEED WITHIN UAE AND GLOBALLY AND AGE-RELATED DISEASES
M42’S STRATEGIC INVESTMENT IN JUVENESCENCE WILL ACCELERATE JUVENESCENCE’S CLINICAL PIPELINE AND DRUG DEVELOPMENT CAPABILITIES
42 AND JUVENESCENCE WILL FORM A STRATEGIC PARTNERSHIP TO IDENTIFY AND DEVELOP A PIPELINE OF AI-ENABLED THERAPEUTICS TO EXTEND HEALTHY LIFESPAN AND ADVANCE THE TREATMENT OF LIFE-THREATENING DISEASES